GLP-1 receptor agonists (GLP-1 RA) are peptide derivatives of either exendin-4 or human GLP-1 designed to resist the activity of DPP-4 and therefore, have a prolonged half-life
PMCID: PMC12355393
Overall, the discontinuation rate for serious adverse events between Semaglutide and placebo was similar
Anti-Doping Agency) tested black-market peptide products and found that over 20% were mislabeled or contaminated
Let your provider know about specific medications such as lithium or drugs with potassium
Microdosing GLP-1 Receptor Agonists During Perimenopause: A Clinical Approach to Hormonal Weight Gain Written and edited by Sarah Bonza MD, MPH, FAAFP, MSCP, DipABLM, NBC-HWC Perimenopause represents a challenging time for women, with up to 70% experiencing weight gain due to declining estrogen levels, decreased energy expenditure, and metabolic changes